We built a Conscious Intelligence platform that perceives the entire life sciences lifecycle as a single, interconnected system, not isolated functions operating in silos. From early-stage science and funding landscape analysis through regulatory strategy, clinical trial design, intellectual property positioning, and commercial launch, every intelligence output is grounded in domain science and constrained by the regulatory, clinical, and commercial realities that determine whether a therapy reaches patients or dies in the pipeline.
Most life sciences organizations operate in silos. Regulatory, clinical, IP, and commercial teams each work from disconnected intelligence. The result: billion-dollar decisions made on partial, manually assembled information.
WISE-R treats the entire lifecycle as one coupled system. A signal in early research connects to regulatory pathways, trial design, IP positioning, and commercial strategy, continuously and autonomously.
We serve biotech, pharmaceutical companies, research institutions, and government health agencies navigating the full complexity from discovery to patient delivery.
Continuous monitoring, analysis, and decision-grade insight across the global clinical trial landscape. Protocol design intelligence, site selection, competitive enrollment tracking, endpoint analysis, and regulatory submission readiness, all connected to the broader pipeline picture.
Real-time mapping of the global funding landscape, NIH, ERC, BARDA, private foundations, venture capital, and government grants, connecting funding signals to research programs, institutional capabilities, and commercialization timelines before opportunities close.
Continuous tracking of regulatory pathways, agency guidance, approval precedents, and submission requirements across FDA, EMA, PMDA, and 200+ country regulatory bodies, connected to the clinical and IP strategy the regulatory decision will affect.
Patent landscape analysis, freedom-to-operate assessment, licensing opportunity identification, and technology transfer lifecycle management with built-in CRM and program management, giving institutions a single platform from invention disclosure through commercialization.
Monitoring every development-stage asset across the global pharmaceutical and biotech pipeline, surfacing competitive threats, partnership opportunities, white-space analysis, and market positioning intelligence before competitors see the same signals.